Affymetrix Company Profile (NASDAQ:AFFX)

About Affymetrix (NASDAQ:AFFX)

Affymetrix logoAffymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Diagnostics & Testing
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:AFFX
  • CUSIP: 00826T10
  • Web: www.affymetrix.com
Average Prices:
  • 50 Day Moving Avg: $14.15
  • 200 Day Moving Avg: $11.20
  • 52 Week Range: $8.28 - $16.15
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 32.58
  • P/E Growth: 0.00
Profitability:
  • Net Margins: 4.24%
  • Return on Equity: 4.84%
  • Return on Assets: 2.97%
Misc:
  • Average Volume: 3.49 million shs.
 

Frequently Asked Questions for Affymetrix (NASDAQ:AFFX)

What is Affymetrix's stock symbol?

Affymetrix trades on the NASDAQ under the ticker symbol "AFFX."

How were Affymetrix's earnings last quarter?

Affymetrix, Inc. (NASDAQ:AFFX) announced its quarterly earnings results on Wednesday, February, 17th. The company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.11 by $0.02. The company earned $95.60 million during the quarter, compared to the consensus estimate of $93.29 million. Affymetrix had a return on equity of 4.84% and a net margin of 4.24%. During the same quarter in the prior year, the firm earned $0.09 earnings per share. View Affymetrix's Earnings History.

Who are some of Affymetrix's key competitors?

How do I buy Affymetrix stock?

Shares of Affymetrix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Affymetrix's stock price today?

One share of Affymetrix stock can currently be purchased for approximately $14.01.


MarketBeat Community Rating for Affymetrix (NASDAQ AFFX)
Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  286
MarketBeat's community ratings are surveys of what our community members think about Affymetrix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Affymetrix (NASDAQ:AFFX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Affymetrix (NASDAQ:AFFX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/3/2016Cantor FitzgeraldReiterated RatingHold$14.00N/AView Rating Details
3/23/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
2/18/2016Cowen and CompanyBoost Price TargetMarket Perform$10.00 -> $14.00N/AView Rating Details
1/11/2016MizuhoDowngradeBuy -> Neutral$14.00N/AView Rating Details
(Data available from 9/23/2015 forward)

Earnings

Earnings History for Affymetrix (NASDAQ:AFFX)
Earnings by Quarter for Affymetrix (NASDAQ:AFFX)
Earnings History by Quarter for Affymetrix (NASDAQ AFFX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/17/2016Q415$0.11$0.09$93.29 million$95.60 millionViewN/AView Earnings Details
10/28/2015Q315$0.08$0.10$88.04 million$86.50 millionViewListenView Earnings Details
7/29/2015Q215$0.07$0.12$88.61 million$89.00 millionViewListenView Earnings Details
4/29/2015Q115$0.04$0.10$87.30 million$88.70 millionViewListenView Earnings Details
2/4/2015Q414$0.07$0.09$91.80 million$93.50 millionViewListenView Earnings Details
10/30/2014Q314$0.04$0.08$84.40 million$87.10 millionViewListenView Earnings Details
7/31/2014Q214$0.03$0.07$83.30 million$85.40 millionViewListenView Earnings Details
5/1/2014Q114$0.02$0.03$81.10 million$83.00 millionViewListenView Earnings Details
2/5/2014Q413$0.07$0.02$89.98 million$92.60 millionViewListenView Earnings Details
7/31/2013Q2 2013($0.01)$0.04$78.53 million$79.46 millionViewListenView Earnings Details
4/30/2013Q1 2013($0.02)($0.01)$78.04 million$77.90 millionViewListenView Earnings Details
1/31/2013Q4 2012($0.03)($0.02)$84.06 million$84.40 millionViewListenView Earnings Details
11/5/2012Q312($0.03)($0.03)$84.56 million$79.60 millionViewN/AView Earnings Details
7/31/2012($0.08)($0.02)ViewN/AView Earnings Details
5/3/2012($0.10)($0.06)ViewN/AView Earnings Details
11/2/2011($0.04)($0.10)ViewN/AView Earnings Details
7/27/2011($0.04)($0.05)ViewN/AView Earnings Details
2/2/2011$0.02$0.06ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Affymetrix (NASDAQ:AFFX)
Current Year EPS Consensus Estimate: $0.39 EPS
Next Year EPS Consensus Estimate: $0.43 EPS

Dividends

Dividend History for Affymetrix (NASDAQ:AFFX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Affymetrix (NASDAQ:AFFX)
Insider Trades by Quarter for Affymetrix (NASDAQ:AFFX)
Institutional Ownership by Quarter for Affymetrix (NASDAQ:AFFX)
Insider Trades by Quarter for Affymetrix (NASDAQ:AFFX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/15/2015Robert H TriceDirectorSell2,500$9.40$23,500.00View SEC Filing  
11/17/2015Robert H TriceDirectorSell2,500$9.00$22,500.00View SEC Filing  
10/15/2015Robert H TriceDirectorSell2,500$9.00$22,500.00View SEC Filing  
7/20/2015Frank WitneyCEOSell37,991$11.20$425,499.20View SEC Filing  
7/10/2015Frank WitneyCEOSell62,756$11.00$690,316.00View SEC Filing  
6/26/2015Frank WitneyCEOSell75,000$11.22$841,500.00View SEC Filing  
6/22/2015David A WeberEVPSell33,879$12.00$406,548.00View SEC Filing  
6/19/2015David A WeberEVPSell14,760$12.00$177,120.00View SEC Filing  
6/4/2015Frank WitneyCEOSell75,000$11.78$883,500.00View SEC Filing  
2/17/2015Gavin WoodCFOSell1,300$11.40$14,820.00View SEC Filing  
1/20/2015Gavin WoodCFOSell22,500$11.77$264,825.00View SEC Filing  
1/12/2015Gavin WoodCFOSell10,200$10.77$109,854.00View SEC Filing  
12/29/2014Gavin WoodCFOSell18,734$10.20$191,086.80View SEC Filing  
11/19/2013Robert TriceDirectorSell6,205$7.98$49,515.90View SEC Filing  
8/21/2012Timothy C BarabeCFOBuy10,000$3.75$37,500.00View SEC Filing  
8/17/2012Timothy C BarabeCFOBuy5,550$3.99$22,144.50View SEC Filing  
8/13/2012Timothy C BarabeCFOBuy4,450$3.99$17,755.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Affymetrix (NASDAQ:AFFX)
Latest Headlines for Affymetrix (NASDAQ:AFFX)
Source:
DateHeadline
nasdaq.com logoLuminex Partners Sutter Health to Boost Molecular Testing
www.nasdaq.com - August 30 at 3:44 PM
americanbankingnews.com logoVeracyte (VCYT) and Affymetrix (AFFX) Financial Contrast
www.americanbankingnews.com - August 24 at 4:24 PM
americanbankingnews.com logoDIGILITI MONEY (DGLT) & Affymetrix (AFFX) Critical Survey
www.americanbankingnews.com - July 14 at 12:54 PM
americanbankingnews.com logoDIGILITI MONEY (DGLT) and Affymetrix (AFFX) Head-To-Head Analysis
www.americanbankingnews.com - June 15 at 2:08 PM
americanbankingnews.com logoAffymetrix (AFFX) vs. MKS Instruments (MKSI) Head to Head Comparison
www.americanbankingnews.com - June 6 at 12:04 PM
streetinsider.com logoForm N-PX CAPSTONE SERIES FUND For: Jun 30 - StreetInsider.com
www.streetinsider.com - July 29 at 3:20 PM
nasdaq.com logoLarry Robbins' Largest –st-Quarter Sales
www.nasdaq.com - June 10 at 9:01 PM
thestreet.com logoThermo Fisher Demonstrates Impressive Quarter
www.thestreet.com - April 28 at 10:42 AM
finance.yahoo.com logoThermo Fisher posts higher profit, revenue; raises forecast
finance.yahoo.com - April 28 at 6:02 AM
finance.yahoo.com logoInside Thermo Fisher’s Affymetrix Acquisition: A Growth Gauge
finance.yahoo.com - April 7 at 2:05 PM
thestreet.com logoAffymetrix (AFFX) Stock Retreats After Origin Withdraws Takeover Bid
www.thestreet.com - March 29 at 9:55 AM

Social

Chart

Affymetrix (AFFX) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff